Safety evaluation for new drug approval in Korea

被引:0
|
作者
Kim, YO [1 ]
Ha, KW
Choi, KS
机构
[1] Korea Food & Drug Adm, Natl Inst Toxicol Res, Gen Toxicol Div, Eunpyung Ku, Seoul 122704, South Korea
[2] Korea Food & Drug Adm, Natl Inst Toxicol Res, Dept Toxicol, Eunpyung Ku, Seoul 122704, South Korea
来源
DRUG INFORMATION JOURNAL | 2001年 / 35卷 / 01期
关键词
toxicity guidelines; Korea; new drug approval;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Current drug regulation in Korea is based on the Pharmaceutical Affairs Law, which has been revised 14 times. Toxicity guidelines are described in the Regulation for Evaluation on Safety and Efficacy of Drugs (Korea Food and Drug Administration Notification No. 1999-60, revised on December 22, 1999) and Guidelines for Toxicity Studies of Drugs (Korea Food and Drug Administration Notification No. 1999-61, revised on December 22, 1999). This paper describes the review process and toxicity guidelines for new drug approval in Korea.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 50 条
  • [31] Regulation of New Drug Approval in Taiwan
    Yang, Ya-Ting
    Huang, Hsiau-Wen
    Chen, Ya-Ting
    Chiang, Yu-Mei
    Tzou, Meir-Chyun
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (05) : 602 - 608
  • [32] New Drug Approval for Weight Management
    不详
    NURSING FOR WOMENS HEALTH, 2024, 28 (01)
  • [33] Access and Safety-The FDA Drug Approval Conundrum
    Good, Chester B.
    Peasah, Samuel K.
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [34] Canadian and US drug approval times and safety considerations
    Rawson, NSB
    Kaitin, KI
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1403 - 1408
  • [35] The Complexity of Integrating Speed and Safety in Drug Development and Approval
    Charo, R. Alta
    JAMA INTERNAL MEDICINE, 2013, 173 (13) : 1165 - 1166
  • [36] New initiatives for pharmacovigilance in South Korea: introducing the Korea Institute of Drug Safety and Risk Management (KIDS)
    Shin, Ju-Young
    Jung, Sun-Young
    Ahn, So-Hyeon
    Lee, Shin Haeng
    Kim, Su-Jin
    Seong, Jong-Mi
    Chung, Soo-Youn
    Park, Byung-Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (11) : 1115 - 1122
  • [37] Drug evaluation and approval process in the European Union
    San Miguel, MT
    Vargas, E
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (01): : 12 - 14
  • [38] NEW DRUG APPROVAL TIMES AND SAFETY WARNINGS IN THE UNITED STATES AND CANADA, 1992-2011
    Rawson, Nigel S. B.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2013, 20 (02): : E67 - E81
  • [39] Early drug safety evaluation: Synergising new technologies
    Gautier, JC
    Boitier, E
    Leonard, JF
    Marchandeau, JP
    Roberts, R
    DRUG METABOLISM REVIEWS, 2003, 35 : 18 - 18
  • [40] Safety issues of new drugs following the approval
    Ludwig, W-D
    ONKOLOGIE, 2011, 34 : 218 - 219